WESTPLEX INTEGRATIVE HEALTHCARE

Early Cancer Detection with the Galleri® Multi-Cancer Test

The Galleri test represents a groundbreaking advancement in cancer screening technology - a single blood draw that can detect signals shared by more than 50 types of cancer, potentially years before traditional detection methods. This innovative screening tool is particularly valuable for detecting aggressive cancers that often don't present symptoms in early stages, offering a revolutionary way to look for signals associated with active cancer.

How Galleri Transforms Cancer Detection

Traditional cancer screening methods are typically limited to a few specific types of cancer, leaving many aggressive cancers undetected until symptoms appear. The Galleri test addresses this gap by using advanced genomic science to analyze cell-free DNA (cfDNA) in your blood. When cancer is present, it can shed DNA into the bloodstream, carrying specific methylation patterns. The test looks for these distinct patterns that may signal the presence of cancer and can help predict where in the body the cancer signal originated. Unlike genetic tests that assess your future cancer risk, Galleri specifically looks for signals of active cancer presence.

Comprehensive Cancer Detection

Valuable Information Provided Simply

The test screens for signals shared by over 50 types of cancer, including aggressive cancers like pancreatic and ovarian that often lack early symptoms, head and neck cancers, blood cancers such as lymphomas, gastrointestinal cancers including esophageal and colorectal, liver and bile duct cancers, lung cancer, brain tumors and nervous system cancers, and many others that typically lack routine screening options. Many of these are fast-spreading, aggressive cancers that don't show symptoms in early stages, making early detection through traditional methods challenging.

Clinical Research and Validation

Clinical studies published in Annals of Oncology have demonstrated the Galleri test's remarkable capabilities in cancer detection. The test successfully detected cancer signals from more than 50 different cancer types, and when cancer was detected, it accurately predicted the cancer signal origin with 89% accuracy. The test maintains a very low false positive rate of less than 1% and shows particular effectiveness in detecting aggressive cancers that often go undetected in early stages. Through extensive clinical studies involving thousands of participants, Galleri has demonstrated its ability to detect cancer signals across stages I-IV, with better detection in later stages.

The Testing Process

Our Team Supports You Through The Entire Experience

The Galleri screening process begins with a standard blood draw, similar to routine blood work. Your sample is specially prepared and sent to GRAIL's specialized laboratory, where advanced genomic technology analyzes it for cancer signals. Results are typically available within 10 business days. If a cancer signal is detected, the test predicts the tissue type or organ where the cancer signal originated, allowing healthcare providers to interpret results and discuss any necessary follow-up steps.

Who Should Consider Galleri

The test is recommended for adults with an elevated risk for cancer, particularly those aged 50 or older, individuals with a family history of cancer, and people with known risk factors for cancer. Anyone seeking to complement their routine cancer screening program may consider the test. However, it is not recommended for individuals who are pregnant, people 21 years old or younger, or those undergoing active cancer treatment.

Schedule Your Appointment

What is Galleri?

How To Take The Test

Understanding Your Results

Find power in the knowledge of your unique results.

Results from the Galleri test fall into two categories. A "Cancer Signal Not Detected" result indicates no cancer signal was found, though this does not rule out cancer entirely, and regular screening should continue as recommended. A "Cancer Signal Detected" result indicates the presence of a cancer signal and provides the predicted cancer signal origin. This result requires confirmatory diagnostic evaluation, and your healthcare provider will recommend appropriate follow-up testing, such as imaging.

Test Performance and Safety Information

The test costs $950 and is available to anyone without requiring existing patient status. It's performed in GRAIL's CLIA-certified, CAP-accredited laboratory and should be used in addition to, not as a replacement for, recommended cancer screenings. While false positive and false negative results can occur, the test maintains high accuracy standards. All results must be interpreted by healthcare providers in the context of medical history and symptoms.

Laboratory Standards

The Answers To Your Health Matter at Westplex

GRAIL's clinical laboratory maintains certification under Clinical Laboratory Improvement Amendments (CLIA) and accreditation by the College of American Pathologists (CAP). The laboratory follows rigorous quality control procedures and maintains strict chain of custody protocols, ensuring reliable and accurate results. While the test has not yet received FDA clearance, it is regulated under CLIA for high-complexity testing.

Scheduling Your Galleri Test

The process is straightforward and accessible. You can schedule online through our booking system, and no prior appointment or referral is needed. The test is available to both new and existing patients at a cost of $950. Our staff is available to answer any questions about the testing process or scheduling.

Schedule Your Appointment

The Importance of Early Detection

Finding cancer early creates the best chance for successful treatment. The Galleri test offers a new way to detect cancer signals early, potentially before symptoms appear. This advanced screening method complements existing cancer screening programs and provides additional peace of mind in your health journey.

Getting Started

Schedule your Galleri test through our online booking system or call our office for assistance. No referral is required, and you don't need to be an existing patient to access this innovative screening tool. Take this proactive step toward protecting your health by scheduling your test today.

The Galleri test is laboratory-developed and its performance characteristics were determined by GRAIL. The test is run in GRAIL's CLIA-certified, CAP-accredited laboratory. The test has not been cleared or approved by the Food and Drug Administration. The test is intended for clinical purposes.

Schedule your Galleri test today and take an important step toward early cancer detection. Our team is ready to guide you through this innovative screening process and answer any questions you may have about the test.

Why Choose Galleri at Westplex Integrative Healthcare

Our knowledgeable healthcare team takes time to explain the testing process and results, ensuring you understand how this valuable screening tool fits into your overall healthcare strategy. We provide comprehensive support throughout the process, from initial consultation through results interpretation.